Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 0.31623 | uM | 3 | 156.25 | 80.34 | 77.00 | 74.50 | 1.0336 | 0.4773 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 156.25 | 80.34 | 113.00 | 74.50 | 1.5168 | -0.9563 |
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 156.25 | 80.34 | 70.00 | 74.50 | 0.9396 | 2.5432 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 3 | 156.25 | 80.34 | 92.00 | 74.50 | 1.2349 | -0.7116 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 57.00 | 74.50 | 0.7651 | 22.3543 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 46.00 | 74.50 | 0.6175 | 166.1398 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 76.00 | 74.50 | 1.0201 | 0.6656 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 60.00 | 74.50 | 0.8054 | 13.5846 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 156.25 | 80.34 | 84.00 | 74.50 | 1.1275 | -0.3353 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 156.25 | 80.34 | 159.00 | 74.50 | 2.1342 | -0.9981 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 156.25 | 80.34 | 103.00 | 74.50 | 1.3826 | -0.8977 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 156.25 | 80.34 | 104.00 | 74.50 | 1.3960 | -0.9064 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 3 | 156.25 | 80.34 | 106.00 | 74.50 | 1.4228 | -0.9214 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 156.25 | 80.34 | 124.00 | 74.50 | 1.6644 | -0.9814 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 156.25 | 80.34 | 158.00 | 74.50 | 2.1208 | -0.9980 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 156.25 | 80.34 | 148.00 | 74.50 | 1.9866 | -0.9963 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 156.25 | 80.34 | 137.00 | 74.50 | 1.8389 | -0.9925 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 156.25 | 80.34 | 102.00 | 74.50 | 1.3691 | -0.8882 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 82.00 | 74.50 | 1.1007 | -0.1708 | |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 156.25 | 80.34 | 74.00 | 74.50 | 0.9933 | 1.1275 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 81.00 | 74.50 | 1.0872 | -0.0719 | |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 156.25 | 80.34 | 102.00 | 74.50 | 1.3691 | -0.8882 |
| SK-BR-3 | Etoposide | 0.01 | uM | 3 | 156.25 | 80.34 | 106.00 | 74.50 | 1.4228 | -0.9214 |
| SK-BR-3 | Etoposide | 1 | uM | 3 | 156.25 | 80.34 | 95.00 | 74.50 | 1.2752 | -0.7852 |
| SK-BR-3 | PLX-4720 | 10 | uM | 3 | 156.25 | 80.34 | 88.00 | 74.50 | 1.1812 | -0.5663 |